| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Indivior Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 317,940 | $10,809,960 | $34.00 | 10 Feb 2026 | Direct |
| Indivior Pharmaceuticals, Inc. | Chief Financial Officer | Performance Stock Units | 113,510 | 09 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INDV | Indivior Pharmaceuticals, Inc. | 09 Feb 2026 | 2 | $0 | 4 | Chief Financial Officer | 12 Feb 2026, 16:07 |
| INDV | INDIVIOR PLC | 01 Jan 2026 | 0 | $0 | 3 | Chief Financial Officer | 07 Jan 2026, 13:35 |